Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma

Pharmaceutical giants Moderna and Merck said that an experimental vaccine treatment has shown signs of preventing skin cancer from returning or spreading in a study of melanoma patients.

Rob Wile
Author: Rob Wile

This post was originally published on NBC News.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *